Background Image
Previous Page  3 / 211 Next Page
Information
Show Menu
Previous Page 3 / 211 Next Page
Page Background

EEG BRAINWAVES SYNCHRONIZATION AND ALPHA BRAINWAVES COMPARISON: STUDY OF PRE AND

POST TREATMENT WITH KENRICO SAP SHEET

Confidential

Property of Kenrico LTD All rights Reserved

Page

3

of

211

Placebo Sap Sheet were made with raw form (non-extract) of wood vinegar, bamboo vinegar,

mushroom chitosan, loquat leaf, houttuynia cordata, mandarin orange, tourmaline, vegetable

fiber and corn flour. As placebo sap sheet were made with raw ingredients, they did not

contain any traces of active ingredients, without sporopollenin and did not have any special

chemical bonding among their active ingredients.

200 participants consist of 95 males and 105 females, ages 21 to 90 with random health

conditions and random stress levels.

To obtain a true randomized result, 50 of the 200 participants were discarded randomly. The

remaining 150 participants were divided into three groups of 50 participants each. The closest

power of 2 (2

n

) with integer 5 as the exponent was selected to obtain the random number for

the three groups. As the final randomized result, 32 (2

5

) participants were assigned to group

one for Site I, 32 (2

5

) participants were assigned to group two for Site II, and 32 (2

5

)

participants were assigned to group three for Site III. Group three is the placebo-controlled

group.

True Randomized Participants

200 participants

95 males and 105 females, ages 21 to

90 with random health conditions and

random stress levels

150 participants

50 of the 200 participants were

discarded randomly

50 participants

Group one

50 participants

Group two

50 participants

Group three

32 final participants

32 (2

5

) participants

were assigned

randomly to group

one for Site I

(experimental group)

32 final participants

32 (2

5

) participants

were assigned

randomly to group

two for Site II

(experimental group)

32 final participants

32 (2

5

) participants

were assigned

randomly to group

three for Site III

(placebo)